News

Deal Announcements

AdvanDx Secures $8 Million Third Venture Capital Round

Thursday, August 20, 2009 5:37:00 AM PDT | VentureDeal Staff
Woburn, Massachusetts  --  Biotechnology diagnostics company AdvanDx has secured $8 million in its third round of institutional venture capital financing.

AdvanDx cell's molecular-based in vitro diagnostic tests that are available in hours instead of days.

SLS Ventures led the round, which also included other undisclosed investors.  The company said that the funding would be used to fund the expansion of its molecular diagnostics product offering as well as sales and marketing initiatives.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1